Monitor for actual execution of the sale on Form 4 filings. The large proposed sale by a major affiliate could create near-term selling pressure. Given the stock's strong recent performance and high analyst bullishness, this may present a buying opportunity on weakness if the sale is completed without further negative news.
Price Chart
Executive Summary
Novo Holdings A/S, a major affiliate shareholder of MapLight Therapeutics, has filed a Form 144 to sell up to 1,600,000 shares of voting common stock, with an approximate market value of $24,032,000 based on the filing date. This represents a significant proposed sale by a large insider/affiliate, signaling potential near-term selling pressure. The filing is notable given the stock's recent strong performance and high analyst bullish sentiment, but the sale by a major holder introduces a bearish overhang.
Key Facts
- Novo Holdings A/S filed Form 144 to sell up to 1,600,000 shares of MapLight Therapeutics common stock.
- The approximate market value of the proposed sale is $24,032,000.
- The shares were acquired through direct investments from the issuer on 10/20/2023, 03/27/2024, and 07/18/2025.
- The filing date is 2026-07-30, and the sale is intended for the open market via Morgan Stanley & Co. LLC.
- Novo Holdings is a former affiliate of the issuer, indicating a large insider/affiliate selling.
- The company has a market cap of $681M, making the proposed sale value approximately 3.5% of market cap.
Financial Impact
Proposed sale of 1,600,000 shares valued at ~$24M, representing ~3.5% of market cap.
Risk Factors
- The sale may not be completed; Form 144 is an intent to sell.
- The large block sale could depress the stock price if executed quickly.
- Insider selling by a major affiliate may signal reduced conviction or a need for liquidity.
- The stock's recent strong performance may be partially driven by momentum that could reverse on selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001388325-26-000032 |
| Document: 0001388325-26-000032-index.html | 0001388325-26-000032 |
| Document: 0001388325-26-000032.txt | 0001388325-26-000032 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.70 (+3.75%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.70 (−0.00%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.70 (−0.00%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.70 (−0.00%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.70 (−28.44%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.70 (−29.36%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.70 (−40.40%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.70 (−40.49%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.70 (+40.86%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.70 (−48.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers